QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

MASI

QT64Masimo Corporation
NASDAQ·Healthcare·Medical - Devices·USA
Latest market price
179.95
+0.00%
OverviewShort InterestFilings
MASIQT64Masimo Corporation·NASDAQ
OverviewShort InterestFilings
179.95+0.00%
TA
Loading chart...
Screen all →
ABT-0.10%$88.41ISRG+1.14%$406.78SYK+2.21%$307.80MDT+1.54%$79.34BSX+0.76%$45.29EW+0.78%$87.36DXCM+1.74%$72.47RMD+1.26%$188.63
Snapshot
Index-P/E123.11EPS (ttm)1.46
Insider Own11.56%
Shs Outstand52.37M
Perf Week0.63%
Market Cap9.42BForward P/E26.79EPS next Y6.72Insider Trans0.18%Shs Float-Perf Month0.86%
Enterprise Value9.79BPEG0.48EPS next Q1.43Inst Own-Short Float-Perf Quarter2.54%
Income76.33MP/S6.05EPS this Y310.62%Inst Trans-Short Ratio-Perf Half Y28.75%
Sales1.56BP/B11.91EPS next Y12.05%ROA4.64%Short Interest-Perf YTD38.36%
Book/sh15.07P/C40.49EPS next 5Y7.42%ROE9.08%52W High179.99 -0.02%Perf Year7.75%
Cash/sh2.39P/FCF45.13EPS past 3/5Y-ROIC18.28%52W Low125.94 42.89%Perf 3Y-
Dividend Est.-EV/EBITDA28.40Sales past 3/5Y-9.14% 5.95%Gross Margin61.73%Volatility0.28% 0.18%Perf 5Y-
Dividend TTM-EV/Sales6.28EPS Y/Y TTM174.48%Oper. Margin19.85%ATR (14)0.31Perf 10Y-
Dividend Ex-DateNov 23, 2012Quick Ratio1.45Sales Y/Y TTM-25.50%Profit Margin4.90%RSI (14)74.86Recom2.60
Dividend Gr. 3/5Y-Current Ratio2.68EPS Q/Q5.15%SMA200.52%Beta0.39Target Price180.00
Payout0.00%Debt/Eq0.62Sales Q/Q8.60%SMA500.71%Rel Volume0.00Prev Close179.95
Employees3,600LT Debt/Eq0.76EarningsAug 04SMA20015.05%Avg Volume809.00KPrice179.95
IPO DateAug 08, 2007Option/ShortYes / YesEPS/Sales Surpr.1.42% 0.25%Net Debt/EBITDA1.05Volume0Change0.00%
Analyst Ratings
DateActionAnalystRatingTarget
Mar-27-26DowngradeRaymond JamesOutperform → Market Perform
Feb-18-26DowngradeWells FargoOverweight → Equal Weight
Feb-18-26DowngradeBTIGBuy → Neutral
Feb-17-26ReiteratedStifel NicolausBuy$170 → $180
Feb-17-26ReiteratedPiper SandlerOverweight$210 → $180
Dec-05-25ReiteratedWells FargoOverweight$187 → $190
Dec-04-25ReiteratedBTIGBuy$193 → $200
May-07-25ReiteratedBTIGBuy$206 → $193
Dec-18-24ReiteratedPiper SandlerOverweight$165 → $210
Nov-06-24UpgradeRaymond JamesMarket Perform → Outperform$170
Latest News
Jun-11-26
Jun-11-2607:05AM
ResMed: GLP-1 Threats Are OverstatedSeekingAlpha
Jun-10-26
Jun-10-2601:55PM
Danaher Closes Acquisition of Masimo; Maintains Q2, 2026 OutlookYahoo
12:55PM
Danaher Completes Acquisition of Masimo CorporationYahoo
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
1/3/2026
FY 2024
12/28/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue1,5601,5272,094
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A5975821,090
Gross Profit9629451,004
Selling, General and Administrative Excl. Other529506744
Research and Development123126223
Other Operating Expense00304
Operating Income310313-267
Interest Expense313344
Unusual Expense
———
Non-Operating Income (Expense)37-5
Net Income Before Taxes275273-305
Income Taxes59650
Consolidated Net Income76-151-305
Net Income From Continuing Operations217208-305
Net Income76-151-305
EPS (Recurring)1.44-2.83-5.72
EPS (Basic, Before Extraordinaries)1.44-2.83-5.72
EPS (Diluted)1.46-2.80-5.72
EBITDA345345-159
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio
123.25——
Price To Sales Ratio6.004.51—
Gross Margin61.6761.8947.95
Operating Margin19.8720.50-12.75
Net Margin4.87-9.89-14.57
Shares Outstanding525453
Market Capitalization9,3576,880—
Operating Lease Expense
———
Insider Trading Volume
$231.29$216.51$201.74$186.97$172.19● Close Price0.00M0.64M1.28M1.92M2.56MUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Scannell Timothy JDirectorApr 29 '26Option Exercise0.002,45002,608May 05 12:00 AM
LANE WENDY EDirectorApr 29 '26Option Exercise0.002,45002,608May 05 12:00 AM
Brennan Michelledirector, other: Chairman of the BoardApr 29 '26Option Exercise0.002,45008,543May 05 12:00 AM
Hellmann Elisabeth AChief Human Resources OfficerApr 21 '26Option Exercise0.0067001,005May 05 12:00 AM
Szyman Catherine M.CEOMar 11 '26Option Exercise0.004,20208,674Mar 16 12:00 AM
Young Micah WEVP & Chief Financial OfficerMar 11 '26Option Exercise0.001,746026,127Mar 16 12:00 AM
Young Micah WEVP & Chief Financial OfficerFeb 27 '26Option Exercise0.0015,00000Mar 03 12:00 AM
Szyman Catherine M.CEOFeb 12 '26Option Exercise66.4822,2821,481,30722,283Feb 13 12:00 AM
Sampath AnandEVP, Ops & Clinical ResearchJan 28 '26Option Exercise37.8460,0002,270,40059,589Jan 30 12:00 AM
Sampath AnandEVP, Ops & Clinical ResearchJan 28 '26Sale136.8118,6802,555,57040,909Jan 30 12:00 AM
Ahmed OmarCTIO & EVP of EngineeringNov 13 '25Option Exercise76.224,948377,1124,242Nov 17 12:00 AM
Tripodi BlairCOO, Consumer DivisionSep 23 '25Option Exercise71.0630,0002,131,95021,896Sep 25 12:00 AM
Brennan Michelledirector, other: Chairman of the BoardAug 13 '25Buy155.2510015,5257,318Aug 14 12:00 AM
Brennan Michelledirector, other: Chairman of the BoardAug 12 '25Buy150.3510015,0357,218Aug 14 12:00 AM
Jellison William RDirectorAug 11 '25Buy145.983,000437,9404,790Aug 12 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR